Quelle place encore pour le traitement de ménopause ?

Rossouw, 2002, Prentice Rea. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Anderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001/jama.291.14.1701 Fournier, 2011, Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts, Menopause, 18, 219, 10.1097/gme.0b013e3181ecf3ec Daubisse-Marliac, 2011, Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries, Ann Oncol, 22, 329, 10.1093/annonc/mdq396 Canonico, 2010, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study, Arterioscler Thromb Vasc Biol, 30, 340, 10.1161/ATVBAHA.109.196022 Renoux, 2010, Hormone replacement therapy and the risk of venous thromboembolism: a population-based study, J Thromb Haemost, 8, 979, 10.1111/j.1538-7836.2010.03839.x Renoux, 2010, Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study, BMJ, 340, c2519, 10.1136/bmj.c2519 Lokkegaard, 2008, Hormone therapy and risk of myocardial infarction: a national register study, Eur Heart J, 29, 2660, 10.1093/eurheartj/ehn408 de Vries, 2006, Myocardial infarction risk and hormone replacement: differences between products, Maturitas, 53, 343, 10.1016/j.maturitas.2005.06.004 Fournier, 2008, Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study, Breast Cancer Res Treat, 107, 103, 10.1007/s10549-007-9523-x Lyytinen, 2010, A case-control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well, Int J Cancer, 126, 483, 10.1002/ijc.24738 Bakken, 2011, Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition, Int J Cancer, 128, 144, 10.1002/ijc.25314 Newcomb, 2008, Prediagnostic use of hormone therapy and mortality after breast cancer, Cancer Epidemiol Biomarkers Prev, 17, 864, 10.1158/1055-9965.EPI-07-0610 Chlebowski, 2010, Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women, JAMA, 304, 1684, 10.1001/jama.2010.1500 Fournier, 2009, Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?, J Clin Oncol, 27, 5138, 10.1200/JCO.2008.21.6432 McTiernan, 2003, Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study, JAMA, 290, 1331, 10.1001/jama.290.10.1331 Kerlikowske, 2010, Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use, J Clin Oncol, 28, 3830, 10.1200/JCO.2009.26.4770 Ritte, 2012, Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study, Breast cancer research, 14, R76, 10.1186/bcr3186 de Lauzon-Guillain, 2009, Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Generale de l’Education Nationale (E3N) cohort, Diabetologia, 52, 2092, 10.1007/s00125-009-1456-y Petracci, 2011, Risk factor modification and projections of absolute breast cancer risk, J Natl Cancer Inst, 103, 1037, 10.1093/jnci/djr172 Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. a randomized, double-blind, placebo-controlled trial, Ann Inter Med, 138, 1, 10.7326/0003-4819-138-1-200301070-00005 Margolis, 2004, Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial, Diabetologia, 47, 1175, 10.1007/s00125-004-1448-x